IGPH
IGEA Pharma N.V.
Save
505.55K
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
IGEA Pharma N. V. commercializes health-tech and med-tech products and devices in in the United States and the Netherlands. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand; and COVID19 rapid test for the detection of IgM and IgG SARS-CoV-2 related antibodies.
Similar securities
Based on sector and market capitalization
Report issue